Puma Biotechnology, Inc. (PBYI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 3.8100 |
| Open | 3.8100 |
| Bid | 3.8300 x 100 |
| Ask | 3.8600 x 200 |
| Day's Range | 3.7500 - 3.9400 |
| 52 Week Range | 2.1300 - 7.7300 |
| Volume | |
| Avg. Volume | 460,215 |
| Market Cap | 185.719M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | 12.03 |
| EPS (TTM) | 0.3200 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.33 |
Business WirePuma Biotechnology to Join Russell 3000 Index
LOS ANGELES, May 28, 2024--Puma Biotechnology is on the preliminary list of additions to the Russell 3000 Index.
Simply Wall St.With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
Key Insights Given the large stake in the stock by institutions, Puma Biotechnology's stock price might be vulnerable...
ZacksPuma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Sales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
© 2024 Yahoo. All rights reserved.